Adverse incident reporting to the Medical Devices Agency - A review of reports involving Trilucent breast implants

British Journal of Plastic Surgery

Volumn 53, Issue 4, 2000, Pages 313-316

  Austin, A ^a  

^a Medical Devices Agency   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OIL;

ARTICLE; BREAST ENDOPROSTHESIS; CLINICAL PROTOCOL; DEVICE; FEMALE; GOOD MANUFACTURING PRACTICE; HEALTH CARE ORGANIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROSTHESIS FAILURE; QUALITY CONTROL; UNITED KINGDOM;

EID: 0034122255     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjps.2000.3353     Document Type: Article

References (5)

1. The Medical Devices Regulations, Consumer Protection 1994 No 3017.
2. MDA AN 1999(01), Trilucent breast implants: Voluntary recall; issued by MDA, Hannibal House, Elephant and Castle, London SE1 6TQ. March 1999.
3. http://www.medical-devices.gov.uk/tbi-mri.htm
4. Committee on Safety of Medicines, Medicines Control Agency, CSM Freepost, London SW8 5BR.
5. European Regulatory Affairs, MDA, 11th Floor, Hannibal House, Elephant and Castle, London SEI 6TQ, tel 020 7 972 8223, fax 020 7 972 8112.